[HTML][HTML] The mutational profile of immune surveillance genes in diagnostic and refractory/relapsed DLBCLs
M Nesic, M Sønderkær, RF Brøndum, TC El-Galaly… - BMC cancer, 2021 - Springer
Background Diffuse large B-cell lymphoma (DLBCL) is the most frequent lymphoid
neoplasm among adults, and approximately 30–40% of patients will experience relapse …
neoplasm among adults, and approximately 30–40% of patients will experience relapse …
The mutational profile of immune surveillance genes in diagnostic and refractory/relapsed DLBCLs
M Nesic, M Sønderkær, RF Brøndum, TC El-Galaly… - BMC Cancer, 2021 - vbn.aau.dk
BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is the most frequent lymphoid
neoplasm among adults, and approximately 30-40% of patients will experience relapse …
neoplasm among adults, and approximately 30-40% of patients will experience relapse …
The mutational profile of immune surveillance genes in diagnostic and refractory/relapsed DLBCLs.
M Nesic, M Sanderkaer, RF Brandum, TC El-Galaly… - BMC Cancer, 2021 - go.gale.com
Background Diffuse large B-cell lymphoma (DLBCL) is the most frequent lymphoid
neoplasm among adults, and approximately 30-40% of patients will experience relapse …
neoplasm among adults, and approximately 30-40% of patients will experience relapse …
[HTML][HTML] The mutational profile of immune surveillance genes in diagnostic and refractory/relapsed DLBCLs
M Nesic, M Sønderkær, RF Brøndum… - BMC …, 2021 - bmccancer.biomedcentral.com
Diffuse large B-cell lymphoma (DLBCL) is the most frequent lymphoid neoplasm among
adults, and approximately 30–40% of patients will experience relapse while 5–10% will …
adults, and approximately 30–40% of patients will experience relapse while 5–10% will …
The mutational profile of immune surveillance genes in diagnostic and refractory/relapsed DLBCLs
M Nesic, M Sønderkær, RF Brøndum… - BMC …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Diffuse large B-cell lymphoma (DLBCL) is the most frequent lymphoid
neoplasm among adults, and approximately 30-40% of patients will experience relapse …
neoplasm among adults, and approximately 30-40% of patients will experience relapse …
[HTML][HTML] The mutational profile of immune surveillance genes in diagnostic and refractory/relapsed DLBCLs
M Nesic, M Sønderkær, RF Brøndum, TC El-Galaly… - BMC Cancer, 2021 - ncbi.nlm.nih.gov
Background Diffuse large B-cell lymphoma (DLBCL) is the most frequent lymphoid
neoplasm among adults, and approximately 30–40% of patients will experience relapse …
neoplasm among adults, and approximately 30–40% of patients will experience relapse …
The mutational profile of immune surveillance genes in diagnostic and refractory/relapsed DLBCLs.
M Nesic, M Sønderkær, RF Brøndum, TC El-Galaly… - BMC Cancer, 2021 - europepmc.org
Background Diffuse large B-cell lymphoma (DLBCL) is the most frequent lymphoid
neoplasm among adults, and approximately 30-40% of patients will experience relapse …
neoplasm among adults, and approximately 30-40% of patients will experience relapse …
The mutational profile of immune surveillance genes in diagnostic and refractory/relapsed DLBCLs
M Nesic, M Sønderkær, RF Brøndum… - BMC …, 2021 - search.proquest.com
Background Diffuse large B-cell lymphoma (DLBCL) is the most frequent lymphoid
neoplasm among adults, and approximately 30–40% of patients will experience relapse …
neoplasm among adults, and approximately 30–40% of patients will experience relapse …
The mutational profile of immune surveillance genes in diagnostic and refractory/relapsed DLBCLs.
M Nesic, M Sønderkær, RF Brøndum… - BMC …, 2021 - search.ebscohost.com
Background: Diffuse large B-cell lymphoma (DLBCL) is the most frequent lymphoid
neoplasm among adults, and approximately 30–40% of patients will experience relapse …
neoplasm among adults, and approximately 30–40% of patients will experience relapse …
[PDF][PDF] The mutational profile of immune surveillance genes in diagnostic and refractory/relapsed DLBCLs
M Nesic, M Sønderkær, RF Brøndum, TC El-Galaly… - 2021 - bmccancer.biomedcentral.com
Background: Diffuse large B-cell lymphoma (DLBCL) is the most frequent lymphoid
neoplasm among adults, and approximately 30–40% of patients will experience relapse …
neoplasm among adults, and approximately 30–40% of patients will experience relapse …